IQVIA Holdings Inc. (IQV)
| Market Cap | 42.90B |
| Revenue (ttm) | 14.98B |
| Net Income (ttm) | 1.36B |
| Shares Out | 182.01M |
| EPS (ttm) | 7.29 |
| PE Ratio | 32.00 |
| Forward PE | 20.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 105,601 |
| Open | 233.10 |
| Previous Close | 233.98 |
| Day's Range | 233.10 - 235.73 |
| 52-Week Range | 167.42 - 261.73 |
| Beta | 1.52 |
| Analysts | Buy |
| Price Target | 256.80 (+8.97%) |
| Earnings Date | May 2, 2024 |
About IQV
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to ge... [Read more]
Financial Performance
In 2023, IQVIA Holdings's revenue was $14.98 billion, an increase of 3.98% compared to the previous year's $14.41 billion. Earnings were $1.36 billion, an increase of 24.47%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for IQV stock is "Buy." The 12-month stock price forecast is $256.8, which is an increase of 8.97% from the latest price.
News
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strate...
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQV...
IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud
RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO, CA--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce...
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bar...
IQVIA Publishes its 2023 Environmental, Social and Governance Report
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report. The annual report provides a detailed account of the organiz...
IQVIA CFO Ron Bruehlman to Speak at Citi's Unplugged Medtech and Life Sciences Access Day on February 29, 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi's ...
IQVIA quarterly results beat estimates on strong demand for research services
IQVIA Holdings beat Wall Street estimates for fourth-quarter sales and profit on Wednesday, on the back of strong demand for its drug research and development services.
IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the li...
IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, ha...
IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14...
3 Charts For Investors to Watch Tuesday: IQVIA Holdings, BGC Group, WGMI ETF
Here's our daily look at three charts linked to recent news-driven price moves, with key technical levels to watch.
Seven tech stocks that can broaden your exposure beyond the “Magnificent Seven”
During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media coverage, and rightly so. There is no question that this group of companies has been performing very well ...
IQVIA Digital Enablement Named PM360 Trailblazer 2023 Supplier/Vendor of the Year
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of data, analytics, technology solutions and services to the life sciences industry, today announced that IQVIA Dig...
IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore A...
IQVIA Announces Upsizing of its Allocation of New Term B Loans
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Borrower”), allocated a new term B loan due 20...
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), priced an offering of ...
IQVIA Announces Offering of Senior Secured Notes
INNOVATION PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (NYSE:IQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), intends to raise $500,...
IQVIA's Christina Mack Named 2023 PharmaVoice 100 Honoree
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, announced that Dr. Christina Ma...
IQVIA Reports Third-Quarter 2023 Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the li...
IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader...
IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission
RESEARCH TRIANGLE PARK, N.C. & OSLO, Norway--(BUSINESS WIRE)--IQVIA, (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services, and The Coalitio...
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 2023. T...
IQVIA Builds on its Strategic Collaboration with argenx to Provide Safety Systems and Services
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, to...
IQVIA Appoints Richard Staub III President of Research & Development Solutions
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, to...
IQVIA Named a Leader in Pharmacovigilance Solutions in IDC MarketScape Report
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, has been named a Leader in the ...